| Product NDC: | 52584-614 |
| Proprietary Name: | Hydralazine Hydrochloride |
| Non Proprietary Name: | Hydralazine Hydrochloride |
| Active Ingredient(s): | 20 mg/mL & nbsp; Hydralazine Hydrochloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVASCULAR |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52584-614 |
| Labeler Name: | General Injectables & Vaccines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040388 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111019 |
| Package NDC: | 52584-614-01 |
| Package Description: | 1 VIAL in 1 BAG (52584-614-01) > 1 mL in 1 VIAL |
| NDC Code | 52584-614-01 |
| Proprietary Name | Hydralazine Hydrochloride |
| Package Description | 1 VIAL in 1 BAG (52584-614-01) > 1 mL in 1 VIAL |
| Product NDC | 52584-614 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydralazine Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVASCULAR |
| Start Marketing Date | 20111019 |
| Marketing Category Name | ANDA |
| Labeler Name | General Injectables & Vaccines, Inc |
| Substance Name | HYDRALAZINE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |